Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic(TM) Medicine as a Potential Treatment for Phenylketonuria
Stock Information for Synlogic Inc.
Loading
Please wait while we load your information from QuoteMedia.